Laura De Ferrari
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Silent invaders: the role of MPs on epithelium inflammation and damage in airway diseases.
Journal: Frontiers in allergy
Published: December 02, 2025
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy.
Journal: International journal of molecular sciences
Published: February 20, 2024
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.
Journal: Respiratory research
Published: December 19, 2023
Moderate asthma: burden, mechanisms and therapeutic perspectives.
Journal: Current opinion in allergy and clinical immunology
Published: October 25, 2023
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Journal: Biomedicines
Published: May 11, 2023
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps.
Journal: The World Allergy Organization journal
Published: January 28, 2022
Severe asthma: One disease and multiple definitions.
Journal: The World Allergy Organization journal
Published: May 20, 2021
In Vitro Reduction of Interleukin-8 Response to Enterococcus faecalis by Escherichia coli Strains Isolated from the Same Polymicrobial Urines.
Journal: Microorganisms
Published: May 12, 2021
Do the current guidelines for asthma pharmacotherapy encourage over-treatment?
Journal: Expert opinion on pharmacotherapy
Published: May 14, 2020
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
Journal: Respiratory medicine
Published: March 20, 2020
Evolving phenotypes to endotypes: is precision medicine achievable in asthma?
Journal: Expert review of respiratory medicine
Published: January 05, 2020
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.
Journal: Allergy
Published: September 24, 2019
Last Updated: 09/26/2026